| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/31/2011 | US7950270 Method and device for detecting volatile analytes in air samples |
| 05/31/2011 | US7950222 System and method for cleaning combustion soot from exhaust gas treatment sensors |
| 05/31/2011 | CA2623477C Compositions and method for treating pediatric hypogonadism |
| 05/31/2011 | CA2465054C Aequorin as a growth marker in yeast |
| 05/31/2011 | CA2460759C Diagnostic probe detection system |
| 05/31/2011 | CA2451582C Compositions for enhanced catalyzed reporter deposition |
| 05/31/2011 | CA2438661C Yeast screens for agents affecting protein folding |
| 05/31/2011 | CA2435741C Methods and devices for quantitation of glycated protein |
| 05/31/2011 | CA2411338C Method for on-line machine vision measurement, monitoring and control of product features during on-line manufacturing processes |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/31/2011 | CA2301942C Molecular mimetics of meningococcal b epitopes |
| 05/31/2011 | CA2237356C Methods for diagnosis and treatment of bloom's syndrome |
| 05/31/2011 | CA2231772C Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/31/2011 | CA2215328C Novel human cytomegalovirus dna sequences |
| 05/31/2011 | CA2172282C Chiral surfactants and methods for their use in chiral separations |
| 05/26/2011 | WO2011063416A2 Microfluidic devices for the capture of biological sample components |
| 05/26/2011 | WO2011063408A1 Method and apparatus for performing assays |
| 05/26/2011 | WO2011063395A2 Lateral flow device for diagnosing microbial infections |
| 05/26/2011 | WO2011063389A2 Normalization of platelet biomarkers |
| 05/26/2011 | WO2011063388A2 Assay method for target nucleic acid by signal amplification using probe hybridization and restriction |
| 05/26/2011 | WO2011063376A2 Mex3c regulation and target to control obesity and diabetes |
| 05/26/2011 | WO2011063324A2 Microfluidic systems for isolating microvesicles |
| 05/26/2011 | WO2011063309A1 Methods and compositions for treating hedgehog-associated cancers |
| 05/26/2011 | WO2011063283A2 Methods for detecting a mycobacterium tuberculosis infection |
| 05/26/2011 | WO2011063235A2 Peptides, devices, and methods for the detection of ehrlichia antibodies |
| 05/26/2011 | WO2011063048A2 Urinary triaosylceramide (gb3) as a marker of cardiac disease |
| 05/26/2011 | WO2011063045A1 Methods for improving the design, bioavailability, and efficacy of random sequence polymer compositions via serum protein-based detection of random sequence polymer compositions |
| 05/26/2011 | WO2011063043A1 Methods for improving the design, bioavailability, and efficacy of directed sequence polymer compositions via serum protein-based detection of directed sequence polymer compositions |
| 05/26/2011 | WO2011063032A1 Method and apparatus to detect coronary artery calcification or disease |
| 05/26/2011 | WO2011063012A1 Reducing leukocyte interference in competitive immunoassays |
| 05/26/2011 | WO2011063010A1 Reducing leukocyte interference in non-competitive immunoassays |
| 05/26/2011 | WO2011063009A1 Methods, devices, kits and compositions for detecting roundworm |
| 05/26/2011 | WO2011063003A2 Peptides and methods for the detection of lyme disease antibodies |
| 05/26/2011 | WO2011062933A2 Array-based proximity ligation association assays |
| 05/26/2011 | WO2011062931A1 Assays for human nt-pro b-type natriuretic peptide, human pro b-type natriuretic peptide and human b-type natriuretic peptide |
| 05/26/2011 | WO2011062908A1 Treatment of hiv infection |
| 05/26/2011 | WO2011062803A2 Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms |
| 05/26/2011 | WO2011062782A2 Innovative blood platelets biomarker for early diagnosis of alzheimer's disease |
| 05/26/2011 | WO2011062730A1 Apparatus for detecting volatile organic compounds and related methods |
| 05/26/2011 | WO2011062634A2 Monoclonal antibodies and diagnostic uses thereof |
| 05/26/2011 | WO2011062625A2 Physicochemical (pcp) based consensus sequences and uses thereof |
| 05/26/2011 | WO2011062560A1 Method for producing t cell receptor-like monoclonal antibodies and uses thereof |
| 05/26/2011 | WO2011062555A1 Devices and methods for optical detection |
| 05/26/2011 | WO2011062549A1 Method used in a human or animal faeces sample processing system, and a sample processing system |
| 05/26/2011 | WO2011062548A1 System and method for increased fluorescence detection |
| 05/26/2011 | WO2011062471A2 Disposable paraffin microvalve for biomedical applications |
| 05/26/2011 | WO2011062407A2 Method and device for detecting analytes |
| 05/26/2011 | WO2011062405A2 Lateral flow immunoassay device |
| 05/26/2011 | WO2011062381A2 Porous detecting sensor and a production method therefor |
| 05/26/2011 | WO2011062377A2 Apparatus and method for quantifying binding and dissociation kinetics of molecular interactions |
| 05/26/2011 | WO2011062270A1 Method for protecting analyte peptide and method for collecting analyte peptide |
| 05/26/2011 | WO2011062174A1 Electrophoretic analysis method |
| 05/26/2011 | WO2011062157A1 Organic colored microparticles, diagnostic reagent kit containing the same, and in vitro diagnosis method |
| 05/26/2011 | WO2011062013A1 Inducer of selective differentiation into neural stem cells and/or neural precursor cells |
| 05/26/2011 | WO2011061944A1 Fluoroimmunoasssay method |
| 05/26/2011 | WO2011061726A1 Use of an isoform of hla-g as an osteogenesis marker |
| 05/26/2011 | WO2011061662A1 Methods for optimizing petroleum reservoir analysis |
| 05/26/2011 | WO2011061632A2 Grey water diversion system |
| 05/26/2011 | WO2011061487A1 New medical methods and agents for use therein |
| 05/26/2011 | WO2011061441A1 Method for proportioning nitrates and/or nitrites in a neutral medium |
| 05/26/2011 | WO2011061376A2 Use of cd98 as endometrial receptivity marker |
| 05/26/2011 | WO2011061310A1 Method and arrangement for monitoring water quality |
| 05/26/2011 | WO2011061304A1 New diagnostic tools for charcot-marie-tooth disease |
| 05/26/2011 | WO2011061210A1 Composition of multiphase flow |
| 05/26/2011 | WO2011060950A1 Screening method for active substances used for the prevention and treatment of neurodegenerative diseases |
| 05/26/2011 | WO2011060916A1 Assay for quantifying clostridial neurotoxin |
| 05/26/2011 | WO2011060771A1 System and a method for detecting analyte molecules contained in liquid samples |
| 05/26/2011 | WO2011060629A1 Pure iron-fluxing agent |
| 05/26/2011 | WO2011060623A1 Device for detecting analyte in sample |
| 05/26/2011 | WO2011060559A1 Sensor mounted in flip-chip technology at a substrate edge |
| 05/26/2011 | WO2011060558A1 Sensor mounted in flip-chip technology on a substrate |
| 05/26/2011 | WO2011060537A1 Predictive markers for taxane responsiveness and methods of use thereof |
| 05/26/2011 | WO2011060534A1 Trim5alpha mutants and uses thereof |
| 05/26/2011 | WO2011060528A1 Heteropeptides useful for reducing nonspecific adsorption |
| 05/26/2011 | WO2011041715A3 Analyte sensor apparatuses having interference rejection membranes and methods for making and using them |
| 05/26/2011 | WO2011039639A3 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7 |
| 05/26/2011 | WO2011039535A3 Micellar compositions for use in biological applications |
| 05/26/2011 | WO2011021105A3 Generation and reproduction of dna sequences and analysis of polymorphisms and mutations by using error-correcting codes |
| 05/26/2011 | WO2011019516A3 Microfluidic diagnostic device |
| 05/26/2011 | WO2011017077A9 Nanochannel-based sensor system with controlled sensitivity |
| 05/26/2011 | WO2011015602A3 Lung cancer biomarkers |
| 05/26/2011 | WO2011011430A3 Method and apparatus for performing cytometry |
| 05/26/2011 | WO2011011334A3 SYNERGISTIC BIOMARKER ASSAY OF NEUROLGICAL CONDITION USING S-100β |
| 05/26/2011 | WO2011009132A3 Methods and composition for isoprenoid diphosphate synthesis |
| 05/26/2011 | WO2011009052A3 Electroactivated peptides and biosensors |
| 05/26/2011 | WO2011008996A3 Peptides whose uptake in cells is controllable |
| 05/26/2011 | WO2010151714A3 Molecular arrays |
| 05/26/2011 | WO2010147998A3 Quenched fluorophores conjugated to peptides via linkers containing dithio groups |
| 05/26/2011 | WO2010144711A3 Immunological targeting of pathological tau proteins |
| 05/26/2011 | WO2010142984A3 Aspirin assay |
| 05/26/2011 | WO2010135603A3 Method for cancer detection, diagnosis and prognosis |
| 05/26/2011 | WO2010133881A3 Tissue analysis |
| 05/26/2011 | WO2010089538A9 Methods of detecting colorectal cancer |
| 05/26/2011 | WO2010049819A8 Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels |
| 05/26/2011 | WO2007084141A3 Surface-enhanced lanthanide chelates |
| 05/26/2011 | WO2007001943A3 Prefoldin 4 in the treatment and diagnosis of cancer |
| 05/26/2011 | WO2006110621A3 Multiplexed biomarkers for monitoring the alzheimer's disease state of a subject |
| 05/26/2011 | US20110126310 Transgenic maize event mon 87427 and the relative development scale |
| 05/26/2011 | US20110126304 Method for distinguishing secretory granules of different ages |
| 05/26/2011 | US20110126302 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |